• Evommune Chief Business & Legal Officer Gregory S. Moss sold 14,223 common shares on May 28, 2026 for USD 22.83 each.
• He acquired 14,223 common shares at USD 1.71 through an employee stock option exercise on the same day.
• Directly held common shares fell to 60,835 following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Evommune Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001742496-26-000005), on June 01, 2026, and is solely responsible for the information contained therein.